PB
MRNA icon

Pinnacle Bancorp’s Moderna MRNA Stock Holding History

Pinnacle Bancorp’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-100
Closed -$2.83K – 940
2025
Q1 		$2.83K Hold
100
– – ﹤0.01% 830
2024
Q4 		$4.16K Hold
100
– – ﹤0.01% 809
2024
Q3 		$6.68K Hold
100
– – ﹤0.01% 748
2024
Q2 		$11.9K Hold
100
– – ﹤0.01% 642
2024
Q1 		$10.7K Hold
100
– – ﹤0.01% 651
2023
Q4 		$9.95K Hold
100
– – ﹤0.01% 628
2023
Q3 		$10.3K Hold
100
– – ﹤0.01% 605
2023
Q2 		$12.2K Hold
100
– – ﹤0.01% 570
2023
Q1 		$15.4K Hold
100
– – 0.01% 539
2022
Q4 		$18K Hold
100
– – 0.01% 483
2022
Q3 		$12K Hold
100
– – 0.01% 523
2022
Q2 		$14K Hold
100
– – 0.01% 510
2022
Q1 		$17K Hold
100
– – 0.01% 498
2021
Q4 		$25K Hold
100
– – 0.01% 442
2021
Q3 		$38K Hold
100
– – 0.02% 380
2021
Q2 		$23K Hold
100
– – 0.01% 477
2021
Q1 		$13K Buy
+100
New +$14.5K 0.01% 549

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Pinnacle Bancorp's MRNA Position: Q2 2025 in Review

Pinnacle Bancorp sold out of Moderna (MRNA) in Q2 2025, closing a stake of 100 shares — an estimated $2.83K sold.

Pinnacle Bancorp first reported a position in MRNA in Q1 2021 and held it in 17 quarters. The position peaked at $38K in Q3 2021. 674 funds tracked by Wall St. Rank hold MRNA as of Q2 2025.

  • Pinnacle Bancorp reported no remaining Moderna position as of Q2 2025 after selling out during the quarter.
  • Pinnacle Bancorp sold 100 Moderna shares in Q2 2025, an estimated $2.83K.
  • Pinnacle Bancorp first reported a position in Moderna in Q1 2021 and held it in 17 quarters.
  • Pinnacle Bancorp's Moderna position peaked at $38K in Q3 2021.
  • 674 funds tracked by Wall St. Rank held Moderna as of Q2 2025.

Based on Pinnacle Bancorp's 13F filing for Q2 2025, filed 11 Jul 2025.